Cumberland Pharmaceuticals  logo
Cumberland Pharmaceuticals CPIX
$ 1.08 -3.57%

Quarterly report 2024-Q3
added 11-08-2024

report update icon

Cumberland Pharmaceuticals Financial Statements 2011-2024 | CPIX

Annual Financial Statements Cumberland Pharmaceuticals

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

32 M 50.1 M 47.7 M 76.2 M 84.9 M 110 M 102 M 82.9 M 102 M 88.4 M 83.5 M 123 M

Shares

14.6 M 14.9 M 15 M 15.4 M 15.6 M 15.9 M 16.2 M 16.7 M 17.6 M 18.3 M 19.6 M 20.3 M

Historical Prices

2.2 3.36 3.17 4.86 5.5 6.81 6.16 4.96 5.81 4.7 4.2 6.07

Net Income

-2.44 M -3.85 M -3.34 M -3.54 M -6.96 M -7.98 M -945 K 731 K 2.42 M -2.1 M 5.84 M 5.66 M

Revenue

9.12 M 8.32 M 37.4 M 47.5 M 40.7 M 41.2 M 33 M 33.5 M 36.9 M 32 M 48.9 M 51.1 M

Cost of Revenue

9.12 M 8.81 M 8.65 M 7.42 M 6.02 M 5.42 M 5.96 M - - - - -

Gross Profit

- - 28.8 M 38.8 M 33.4 M 33.8 M 27.1 M 28.6 M 31.8 M 26.6 M 43.8 M 45.8 M

Operating Income

-2.28 M -4.35 M -6.38 M -9.29 M -11.2 M -8.88 M -1.43 M 1.11 M 3.56 M -3.8 M 8.82 M 9.85 M

Interest Expense

586 K 98 K 264 K 246 K 196 K 92.9 K 106 K 73.9 K 67.1 K 103 K 72 K 353 K

EBITDA

3.05 M 252 K -1.95 M 512 K -4.62 M -1.65 M 761 K 3.1 M 5.16 M -2.91 M 9.28 M 10.6 M

Operating Expenses

- - 35.2 M 42.4 M 40.8 M 37.9 M 28.5 M 27.4 M 28.3 M 30.4 M 35 M 35.8 M

General and Administrative Expenses

10.2 M 9.78 M 10.2 M 10.4 M 10.4 M 10 M 8.56 M 7.61 M 8.4 M 9.49 M 9.1 M 9.2 M

All numbers in USD currency

Quarterly Income Statement Cumberland Pharmaceuticals

2024-Q3 2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

14.1 M 14.1 M 14.1 M 14.3 M 14.4 M 14.4 M 14.4 M 14.5 M 14.7 M 14.7 M 14.7 M 14.9 M 15 M 15 M 15 M 15.1 M 15.2 M 15.2 M 15.3 M 15.4 M 15.5 M 15.5 M 15.5 M 15.6 M 15.7 M 15.7 M 16.1 M 15.9 M 16 M 16 M 16.1 M 16.2 M 16.2 M 16.3 M 16.4 M 16.6 M 16.8 M 17 M 17.1 M 17.5 M 17.7 M 17.9 M 18 M 18.2 M 18.4 M 18.8 M 18.9 M 19.4 M 19.8 M 20 M 20 M 20.3 M 20.5 M 20.4 M

Net Income

-1.54 M -1.09 M - -1.05 M 872 K 172 K - -409 K -1.34 M -1.4 M -3.85 M -1.06 M 1.22 M 145 K -884 K -482 K -918 K -1.06 M -961 K -1.95 M -1.95 M -73.9 K -2.22 M -1.64 M -721 K -2.38 M -801 K -743 K -5.16 M -1.27 M -750 K 106 K -48 K -253 K 151 K 127 K 407 K 46.3 K 669 K 746 K 723 K 286 K -1.5 M -820 K -639 K 855 K 1.81 M 1.87 M 1.74 M 423 K 912 K 1.85 M 2.18 M 721 K

Revenue

9.09 M 9.85 M - 10.1 M 10.9 M 9.22 M - 11.4 M 10.3 M 11.2 M 8.32 M 8.07 M 9.06 M 10.5 M 10.3 M 9.25 M 9.6 M 8.33 M 9.31 M 6.94 M 9.42 M 8.73 M 10.5 M 5.85 M 10.2 M 8.59 M 11.6 M 11.2 M 8.67 M 9.64 M 9.08 M 8.79 M 7.41 M 7.74 M 8.04 M 7.89 M 8.91 M 8.69 M 9.33 M 9.73 M 9.75 M 8.09 M 8.16 M 6.53 M 7.08 M 10.3 M 13.7 M 12.5 M 12.4 M 10.3 M 13 M 13.1 M 14.4 M 10.7 M

Cost of Revenue

1.32 M 1.71 M - 1.77 M 1.52 M 1.25 M - 2.22 M 2.03 M 2.21 M - 1.33 M 1.74 M 2.42 M - 2.14 M 2.61 M 1.63 M - 1.58 M 5.03 M 1.66 M - 1.46 M 1.52 M 1.53 M - 2.17 M - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-1.69 M -1.03 M - -1.87 M 22.9 K -1.53 M - -289 K -1.85 M -1.29 M -4.35 M -1.56 M -1.44 M -324 K -1.75 M -1.21 M -1.58 M -1.85 M -3.39 M -3.2 M -3.2 M -1.32 M -3.29 M -2.64 M -1.92 M -3.32 M -903 K -839 K -1.68 M -658 K -957 K 130 K -105 K -501 K 163 K 271 K 674 K 4.12 K 946 K 989 K 1.22 M 408 K -2.47 M -1.51 M -1.14 M 1.33 M 3.25 M 2.98 M 1.94 M 646 K 1.71 M 3.1 M 3.63 M 1.41 M

Interest Expense

137 K 126 K - 110 K 193 K 186 K - 149 K 138 K 120 K - 20 K 25.9 K 24.4 K - 75.2 K 119 K 33.1 K - 64.9 K 217 K 60.9 K - 19.2 K 22 K 18.3 K - 8.9 K 30 K 31.7 K - 29.1 K 28.2 K 20.4 K - 19.8 K 18.5 K 15.6 K - 26.9 K 12.3 K 12.2 K - 24.3 K 20.7 K 17.7 K - 17.2 K 16.7 K 22.4 K - 33.4 K 79.6 K 216 K

EBITDA

-616 K 73.2 K - -691 K 1.18 M -276 K - 1.2 M -317 K 362 K -4.35 M 1.97 M 1.02 M 903 K -1.75 M 2.32 M 754 K -694 K -3.39 M -2.16 M 82.5 K -248 K -3.29 M -537 K -524 K -2.62 M -903 K 1.13 M -367 K 3.68 K -957 K 1.92 M 1.07 M 81.5 K 163 K 1.95 M 1.82 M 565 K 946 K 2.37 M 2.02 M 803 K -2.47 M -598 K -530 K 1.62 M 3.25 M 3.64 M 2.38 M 863 K 1.71 M 3.9 M 4.16 M 1.67 M

Operating Expenses

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

2.68 M 2.76 M - 2.34 M 2.37 M 2.5 M - 2.17 M 2.2 M 2.3 M - 2.04 M 2.1 M 2.23 M - 2.38 M 2.19 M 2.04 M - 2.03 M 6.84 M 2.54 M - 2.07 M 2.33 M 2.33 M - 2.09 M 2.35 M 2.11 M - 1.87 M 1.87 M 2.08 M - 1.79 M 2.15 M 1.64 M - 2.16 M 2.14 M 1.9 M - 1.96 M 1.86 M 2.58 M - 1.89 M 2.15 M 2.27 M - 2.15 M 2.37 M 2 M

All numbers in USD currency